Z-1075-2013 Class III Terminated
FDA device recall Z-1075-2013 was initiated by Tosoh Bioscience Inc on Aug 18, 2010 and is designated Class III. Reason for recall: The Beta-thalessemia Mode of the G7 Analyzer-Beta Thalassemia Mode is an automated High Performance Liquid Chromatography (HPLC) system that separates and reports HbF and HbA2 quantitative percentages… The recall status is terminated (terminated May 13, 2014). Affected quantity: 633.
Recall details
- Product Type
- Devices
- Report Date
- Apr 17, 2013
- Initiation Date
- Aug 18, 2010
- Termination Date
- May 13, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 633
Product description
Reason for recall
Distribution pattern
Worldwide Distribution-USA (nationwide) including DC, Puerto Rico, Virgin Islands and the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI and WV, and the countries of Canada, Columbia, Chile, Brazil, and Jamaica.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1075-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026